Valeria Sorrenti1*
Cinzia Lucia Randazzo2
Cinzia Caggia2
Gabriele Ballistreri3
Flora Valeria Romeo3
Simona Fabroni3
Nicolina Timpanaro3
Marco Raffaele1
Luca Vanella1- 1Dipartimento di Scienze del Farmaco, Sezione di Biochimica, Università di Catania, Catania, Italy
- 2Dipartimento di Agricoltura, Alimentazione e Ambiente – Di3A, Università di Catania, Catania, Italy
- 3Council for Agricultural Research and Economics (CREA) – Research Centre for Olive, Citrus and Tree Fruit, Acireale, Italy
The beneficial effects of pomegranate are due to the ellagitannins and anthocyanins content, which are protective toward a wide variety of diseases including inflammatory diseases. Many investigators have reported that pomegranate waste (peel and seeds) extracts, made from waste product of industrial processing, show free radical scavenger and a potent antioxidant capacity. Pomegranate extracts (PEs) were also reported to possess noteworty antibacterial, antiviral, hypolipidemic, and anti-inflammatory bioactivities thanks to the polyphenolic compounds content, which includes punicalagins, gallic acid, and ellagic acid derivatives. The focus of the present manuscript was to study the prebiotic potentiality of a PE, soluble in water, and characterized through HPLC–PDA–ESI/MSn for its phenolic content. Moreover, since it has been reported that pomegranate extracts decreased the level of lipids in the blood and that a number of probiotic strains have been shown to affect adipogenesis in cell culture, this study was also performed to test the in vitro effects of PE and probiotic L. rhamnosus GG ATCC 53103 strain (LGG) on 3T3-L1 cell line. PE and probiotics substantially reduced the triglyceride content and intracellular lipid increase, compared to the control group. However, the combination treatment of PE and LGG filtered spent broth (SB) was the most effective in reducing triglyceride content and intracellular lipid accumulation. The mRNA expression levels of the main transcriptional factors implicated in adipocyte differentiation were substantially lower in 3T3-L1 cells treated with PE and LGG filtered SB. These results evidenced that a synergistic effect of probiotics and polyphenols contained in PE may affect in vitro adipogenesis and may contribute in development of new nutraceutical/probiotic-based remedies to prevent and to treat obesity.
Introduction
Pomegranate is a fruit whose positive health effects have been extensively studied. This fruit is rich in bioactive compounds such as ellagitannins and anthocyanins content, which are protective toward degenerative diseases. Pomegranate fruit, because of its high nutritive value, health benefits, and antioxidant bioactive compounds, is considered as a food medicine. In fact, pomegranate has been considerably used in herbal medicine for several pathologies including flu and infections of the upper respiratory tract. All parts of the pomegranate fruit, i.e., peel and seeds, considered as waste products, can be processed for value-added products having industrial, medicinal, and cosmetic value (Dhumal et al., 2014).
Pomegranate wastes are produced in all the phases of fruits life cycle, i.e., during agricultural production, industrial manufacturing, and processing. It is possible to take advantage of pomegranate by-products as they are a rich source of bioactive compounds such as flavonoids, phenolic acids, and tannins. Moreover, many researchers have described that pomegranate extracts, made from by-products of the processing factories, have an effective free radical scavenging activity and antioxidant capacity (Lee et al., 2010; Panichayupakaranant et al., 2010; Fischer et al., 2011).
Furthermore, the pomegranate extracts act as natural inhibitors of pathogens, bacteria, and fungi (Al-Zoreky, 2009; Tehranifar et al., 2011; Romeo et al., 2015).
Pomegranate ellagitannins are hydrolyzed by gut microbiota to smaller phenolics, such as ellagic acid. Ellagic acid is then absorbed into the blood circulation, while ellagitannins are not absorbed and are metabolized into urolithins.
It has been reported that pomegranate by-products and punicalagins significantly are able both to inhibit the growth of pathogenic Escherichia coli, Pseudomonas aeruginosa, Clostridia, and Staphylococcus aureus (Reddy et al., 2007; Bialonska et al., 2009) and to increase the growth on beneficial bacteria including Bifidobacterium spp. and Lactobacillus spp. (Reddy et al., 2007; Bialonska et al., 2010).
Pomegranate extracts were also reported to decrease the level of lipids in the blood and to have significant anticancer, antiviral, and anti-inflammatory activities (Li et al., 2006; Hossin, 2009; Lin et al., 2013; Bassiri-Jahromi, 2018).
These potential beneficial effects are attributed to the polyphenolic compounds that the pomegranate extracts contain including punicalagins, gallic acid, and ellagic acid derivatives (Vanella et al., 2013a,b,c; Romeo et al., 2015).
Because obesity is one of the main public health problems, new preventive strategies are necessary (Smith and Smith, 2016).
Adipocyte plays a major role in the begin or development of metabolic complications associated to obesity, such as metabolic syndrome and diabetic complications (Kim and Plutzky, 2016).
The interest of the researchers in the identification of natural products obtained from dietary plants that have anti-obesity activities has increased. It has been reported that the xanthigen and fucoxanthin, natural compounds of pomegranate seed oil, significantly suppressed adipocyte differentiation and lipid accumulation (Lai et al., 2012).
The focus of the present manuscript was firstly to study the antioxidant and antimicrobial activities, and the prebiotic potential of a PE rich in phenolic compounds. Moreover, the enriched standardized PE, containing high percentages of pomegranate natural antioxidants, was chemically characterized through HPLC–PDA–ESI/MSn. Secondly, since pomegranate juice (Les et al., 2018) and different types of pomegranate extracts (PEs), including extract prepared from the whole fruit (Li et al., 2015) and extract derived from pomegranate peel (Neyrinck et al., 2013), and a number of probiotic strains (Moon et al., 2012; Park et al., 2014) have been shown to affect adipogenesis, this study was carried out to test the in vitro effects of PE, probiotic L. rhamnosus GG ATCC 53103 (LGG) preincubated with PE, alone or in combination, on 3T3-L1 cell differentiation.
Materials and Methods
Chemicals
The powdered pomegranate extract (Dermogranate®) employed in this study was provided by Medinutrex (Catania, Italy). Briefly, the extract was prepared from dried and grinded pomegranate fruits mixed with hydroalcoholic solutions (food grade) and then filtered. The filtrate was concentrated and then spray-dryed to obtain the standardized extract. The Dermogranate® extract had the following chemical composition: total polyphenols (16%), punicalagins (8%), ellagic acid, and derivatives (8%).
Folin–Ciocalteu reagent (FCR), sodium carbonate (Na2CO3), gallic acid, punicalin (mixture of anomers), punicalagin, and ellagic acid were purchased from Sigma-Aldrich (Milan, Italy). Granatin B was purchased from LGC Standards (London, United Kingdom). HPLC–MS grade solvents (Merck KgaA, Darmstadt,Germany) were used for chromatography and all other reagents were of analytical grade.
Determination of Total Polyphenols Content
The Folin–Ciocalteu assay (Singleton et al., 1999) was used for the determination of total polyphenols content with slight modifications. 0.1 mg/ml of extract was dissolved in distilled water. Then, 5 ml of 10% FCR and 4.5 ml of Na2CO3 solution (7.5% w/v) were added to 500 μl of sample. The final solution was agitated for 2 h in the dark and then the Abs at λ = 765 nm was measured. Analyses were carried out in triplicate and the concentration of total polyphenols was expressed as g of gallic acid equivalents (GAEs)/100 g of extract.
HPLC–PDA–ESI/MSn Analysis of Phenolic Compounds
Separation and quantification of phenolic compounds were performed as previously described (Romeo et al., 2015). For the identification of phenolic compounds, the retention times (RTs), spectra, and MS data in negative ESI mode were compared to those of authentic standards. Quantification of each phenolic compound was performed using the corresponding standard as external standard. Quantification was carried out at 280 nm for gallic acid. Punicalins, granatin B, punicalagins, and ellagic acid were quantified at 378 nm; the same wavelength was used for the quantification of ellagic acid derivatives using ellagic acid as reference standard. Analyses were carried out in triplicate and the results were expressed as g of compound/100 g of extract.
Quenching of DPPH
The free radical-scavenging capacity of different concentrations of PE extract (3.4–1.7–0.85–0.56–0.42–0.34–0.21–0.17–0.11–0.085–0.028 mg/ml) was measured by 2,2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH)-free radical method as previously reported (Salerno et al., 2012). Results are expressed as percentage of inhibition rate ±SD.
Scavenger Effect on Superoxide Anion
The superoxide anion-scavenging capacity of different concentrations of PE extract (3.4–1.7–0.85–0.56–0.42–0.34–0.21–0.17–0.11–0.085–0.028 mg/ml) was measured as previously reported (Salerno et al., 2012). Results are expressed as percentage of inhibition rate ± SD.
3T3-L1 Murine Pre-adipocytes Cell Viability
3T3-L1 murine pre-adipocytes were bought from American Type Culture Collection (Rockville, MD, United States). Cells were plated at a concentration of 2 × 105 cells per well of a 96-well microplate and cultured at 37°C in incubator with 5% CO2 for 48 h in the absence and presence of the different concentrations of PE reported above. Cell viability was measured by MTT assay as previously reported (Di Giacomo et al., 2015). MTT, a yellow tetrazole, is reduced to purple formazan in living cells. Results are expressed as percentage of formazan produced in treated 3T3-L1 murine pre-adipocytes cells compared to untreated cells.
Microbiology
Bacterial Cultivation
The commercial pathogen strains E. coli ATCC 25922, S. aureus ATCC 29213, Listeria innocua ATCC 33090, and Salmonella enterica ATCC 14028 were used. E. coli strain was grown in Luria-Bertani (LB) broth at 37°C overnight; S. aureus, S. enterica, and L. innocua were routinely grown overnight, in Tryptone Soya Broth (TSB) at 37 and 30°C, respectively. All media and supplements were provided by Oxoid (Milan, Italy).
The commercial probiotic strains LGG, Bifidobacterium animalis BB12, B. longum BB536, and the wild strain Lactobacillus paracasei N 24, isolated from Pecorino crotonese cheese, were cultured in deMan–Rogosa–Sharpe (MRS) broth at 37°C overnight.
Overnight bacterial culture was incubated at 37°C for 24 h, under anaerobic condition, until they reached a cell density of approximately 1.0 × 109 cfu/ml.
Growth Rate Determination
Based on results obtained on free radical scavenger activity of PE and on 3T3-L1 murine pre-adipocytes cell viability experiments, different concentrations were used for treatment of probiotic or pathogen strains as described below.
Antimicrobial activity of the PE was evaluated against the commercial pathogen strains mentioned above. Overnight pathogen cultures were co-cultured at 37°C for 24 h with PE at different concentrations (1.7–0.34–0.17 mg/ml), and the antimicrobial activity was evaluated by plating count of live bacteria and expressed as cfu/ml.
The effect of PE on the growth of probiotic strains mentioned above was evaluated inoculating in co-culture the probiotic strains at a cell density of approximately 1.0 × 109 cfu/ml with the PE at different concentrations (0.085–0.042–0.028 mg/ml). The effect of the extract on growth of probiotic strains was evaluated after incubation at 37°C for 24 h under anaerobic conditions by plating count of live bacteria and expressed as cfu/ml.
All experiment was conducted in duplicate and results were expressed as mean values and standard deviation. Based on preliminary results LGG was chosen for the subsequent analyses.
Fresh broth cultures were centrifuged at 5000 rpm for 10 min at 4°C, and the supernatant was decanted to collect the spent broth (SB), which was filtered (FSB), using a 0.22-μm filter and then used for further analyses.
The bacterial pellet was resuspended in 1 ml of PBS and sonicated five times at 44% amplitude for 2 min with 6 min of rest. The sonicate was then centrifuged at 1100 ×g for 15 min at 4°C. The supernatant was collected, filtered through a 0.22-μm filter, and labeled bacterial cell extract (CE). The CE was used for further analysis.
Cell Culture and Adipocyte Cell Differentiation
3T3-L1 murine pre-adipocytes were resuspended in Dulbecco’s Modified Eagle Medium (DMEM), containing 10% fetal bovine serum (FBS, Invitrogen, Carlsbad, CA, United States) and 1% antibiotic/antimycotic solution (Invitrogen, Carlsbad, CA, United States) and seeded in a 75-cm2 flask at a density of 1 to 2 × 104 cells. Adipocyte cell differentiation was obtained as previously reported (Waldman et al., 2016).
Differentiating 3T3-L1 pre-adipocytes were treated for 7 days with PE (0.028 mg/ml), LGG CE (25 μg/ml), and LGG filtered SB (10 μg/ml) from overnight bacterial culture incubated with or without PE (0.028 mg/ml).
Lipid Content Quantification
To quantify lipid accumulation, Oil Red Staining was performed as previously reported (Barbagallo et al., 2017). Formation of lipid drops was measured with an inverted multichannel LED fluorescence microscope (Evos, Life Technologies, Grand Island, NY, United States).
RNA Extraction and qRT-PCR
Expressions of adiponectin, PPAR-γ, SREBP, FAS, IL-6, and IL-10 were evaluated by real-time PCR. RNA was extracted and quantified as previously reported (Raffaele et al., 2018). Appropriate primer sequences were used (Table 1). The relative mRNA expression level was measured by the threshold cycle (Ct) value of each PCR product and normalized with that of GAPDH by using comparative 2-ΔΔCt method.
Table 1. PCR primers used in this study.
Statistical Analyses
Statistical analyses of multiple comparisons were performed by the Fisher method. P-values lower than 0.05 were accepted as significant. Data were analyzed using either single-factor analysis of variance (ANOVA) for multiple groups, or the unpaired t-test for two groups, and the results are presented as mean ± SD.
Results
HPLC–PDA–ESI/MSn Analysis of PE
The phenolic profile of PE (Figure 1) included the determination of 1 hydroxybenzoic acid and 19 ellagitannins. The main peaks corresponded to punicalin (peak 4), granatin B (peak 6), punicalagin A and B (peaks 10 and 14), and ellagic acid (peak 19) (Figure 1). The presence of gallic acid (peak 1) and ellagic acid derivatives (peaks 2, 3, 5, 7–9, 11–13, 15–18, and 20) was also revealed. As shown in the chromatogram, ellagitannins are the predominant class of phenolic compounds in pomegranate peel and marc (a by-product made up of seeds and peels), since they represent over the 99% of the total content of pomegranate phenolics. Punicalagins, the major ellagitannins of pomegranate by-products, accounted for 47.6% of the total phenolics content in PE (Table 2). Ellagic acid derivatives, ellagic acid, and other minor phenolic compounds (punicalin, granatin B, and gallic acid), accounted for 38.4, 10.2, and 3.8% of the total phenolics content in PE, respectively (Table 2).
Figure 1. HPLC chromatogram of phenolic compounds of PE detected at 378 nm. For the identification of the peaks, see Table 2.
Table 2. Peak list and quantification of the phenolics in PE.
The mass spectrometric properties of the 20 phenolic compounds identified (peaks 1–20) are shown in Table 2. As previously reported (Romeo et al., 2015), two isomeric forms (A and B) of punicalagins (peaks 10 and 14) were observed, as well as the presence of granatin B (peak 6) was highlighted. Furthermore, these compounds were also characterized by direct infusion-negative ion ESI/MSn analysis of standard compounds. Peak 4 was identified as punicalin (m/z 781) while peaks 2, 3, 5, 7–9, 11–13, 15–18, and 20 were identified as ellagic acid derivatives according to their UV–Vis and mass characteristics (λmax around 370 nm and MS1 fragment at m/z 301 corresponding to ellagic acid).
Free Radical Scavenging Activity of PE
Antioxidant activity of PE was tested by their ability to reduce the stable DPPH radical.
Particularly, the percentage of inhibition of DPPH resulted up to 75% at concentrations lower to 0.21 mg/ml (76,78, 79, and 80% respectively, at concentration of PE of 0.17- 0.11- 0.085-and 0.028 mg/ml). At concentrations higher to 0.21 mg/ml the percentage of inhibition of DPPH resulted lower (Figure 2).
Figure 2. DPPH radical scavenging activities of PE at different concentrations. Results are expressed as percentage of inhibition rate ± SD.
Pomegranate extract inhibited superoxide anion formation in a dose-dependent manner (Table 3). As a general trend, in this test PE resulted more effective than in the previous one. This might be due to the smaller size of superoxide anion compared to DPPH radical.
Table 3. Superoxide ion scavenging activities of different concentrations of PE.
Effect of PE on 3T3-L1 Cell Viability
3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay was carried out to evaluate 3T3-L1 cell viability. Results show a significant reduction of cell viability with high concentrations of PE (3.4, 1.7, 0.85, 0.56, and 0.42 mg/ml), whereas lower (0.34, 0.21, 0.17, 0.11, and 0.085 mg/ml) concentrations had a moderate inhibitory effect and 0.028 mg/ml concentration had no significant effect on 3T3-L1 murine pre-adipocytes cell viability (Figure 3).
Figure 3. Percentage of 3T3-L1 murine pre-adipocytes survival in the presence of PE at different concentrations. Results are expressed as the means ± SD of four experiments performed in triplicate. Significant vs. untreated controls: ∗p < 0.005; ∗∗p < 0.05.
Microbiology
Antimicrobial Activity of the PE on Pathogen Strains
Data of co-culture assay have shown that pathogens were differently sensitive to the PE. In detail, as showed in Figure 4, the extract at the concentration of 1.7 mg/ml showed the highest antimicrobial activity against all pathogens, with a significant decrease of L. innocua (proximally 4 log unit). At the concentration of 0.34 mg/ml the extract was efficacy against E. coli, L. innocua, and S. aureus, exhibiting a reduction of cell density of 1 and 2 log units, respectively. When the PE was tested at 0.17 mg/ml concentration, S. aureus, S. enterica, and L. innocua strains were still inhibited, while the growth of E. coli was not significantly affected.
Figure 4. Antimicrobial activity of different concentration of PE on pathogens detected at T24 (24 h of inoculum). The cell density is expressed as Δlog cfu/ml.
Effect of the PE on Growth of Probiotic Strains
Results shown in Table 4 highlighted that PE, at all tested concentrations, did not have any inhibitory activity on growth of probiotic strains tested. A slight increase in growth was observed for LGG co-cultured with PE at concentration of 0.028 mg/ml (Table 4).
Table 4. Bacterial counts expressed as log10 cfu/ml of three replicates ± SD of L. rhamnosus GG ATCC 53103, Bifidobacterium animalis BB12, B. longum BB536, and the wild strain Lactobacillus paracasei N 24 after incubation with PE at different concentrations.
Effect of PE on Lipid Content
Pomegranate extract- and LGG-filtered SB significantly decreased the triglyceride content compared with the control group (Figures 5A,B). However, the effect of filtered SB derived from cells incubated with PE (LGG-T1) or without (LGG-T0) was similar. The simultaneous treatment of 3T3-L1 murine pre-adipocytes with PE- and LGG-filtered SB significantly decreased the triglyceride content compared with the treatment of LGG-filtered SB alone. Moreover, these data evidenced that combination treatment of PE and LGG-T1 was the most effective in reducing triglyceride content and intracellular lipid accumulation.
Figure 5. (A) Representative Oil red O staining of 3T3-L1 cells in absence and in presence of PE, LGG T0, LGG T1, LGG T0 + PE, and LGG T1 + PE. (B) Lipid content was quantified with Oil Red O staining (mean ±SD, ∗p < 0.05 versus control; #p < 0.05 versus LGG T0 and LGG T1; § p < 0.05 versus LGG T0+PE).
The treatment of 3T3-L1 murine pre-adipocytes with LGG cellular extract (CE), derived from cells incubated with PE (CE+PE) or without (CE), had no effect on intracellular lipid accumulation compared with the control group (Control: ABS 490 nm = 0.200 ± 0.07; CE: ABS 490 nm = 0.187 ± 0.09; CE+PE = ABS 490 nm = 0.190 ± 0.05).
Effect of PE on Adipogenic Markers
The mRNA expression levels of the main transcriptional factors involved in adipocyte differentiation were significantly less expressed in 3T3-L1 cells treated with PE- and LGG-filtered SB. Particularly PE, LGG-T0, and LGG-T1 were able to decrease gene levels of Adiponectin, PPAR-γ, SREBP, FAS, and IL-6 and to increase gene levels of IL-10 (Figures 6A–F).
Figure 6. (A–F) Analysis of gene expression by qRT-PCR of lipogenic pathway in 3T3-L1 cells in absence and in presence of PE, LGG T0, LGG T1, LGG T0+PE, and LGG T1+PE. Results are expressed as the means ± SD of four experiments performed in triplicate (∗p < 0.05 versus control; #p < 0.05 versus LGG T0 and LGG T1; § p < 0.05 versus LGG T0+PE).
The simultaneous treatment of 3T3-L1 murine pre-adipocytes with PE- and LGG-filtered SB (LGGT0 and LGGT1) significantly decreased mRNA expression levels of the main transcriptional factors involved in adipogenesis, compared with the treatment of LGG-filtered SB (LGGT0 and LGGT1) alone (Figures 6A–E).
The simultaneous treatment of 3T3-L1 murine pre-adipocytes with PE- and LGG-filtered SB (LGGT0 and LGGT1) significantly increased mRNA expression levels of IL10, compared with the treatment of LGG-filtered SB (LGGT0 and LGGT1) alone (Figure 6F). Moreover, these data evidenced that combination treatment of PE+LGG T1 was the most effective in reducing mRNA expression levels of Adiponectin, IL-6, FAS, and in upregulating IL-10 (Figures 6A,D–F).
Discussion
The beneficial effects of pomegranate fruit and/or juice consumption have received considerable scientific interest (Basu and Penugonda, 2009). Many investigators have reported that PEs, made from a waste product of the processing factories, have a free radical scavenging and potent antioxidant capacity (Panichayupakaranant et al., 2010; Fischer et al., 2011). PE used in the present study was soluble in water, and characterized through HPLC–PDA–ESI/MSn for its phenolic and anthocyanin content. In agreement with previous reports (Fischer et al., 2011; Qu et al., 2012; Romeo et al., 2015), ellagitannins are the predominant class of phenolic compounds in pomegranate peel and marc (a by-product made up of seeds and peels), since they represent over the 99% of the total content of pomegranate phenolics. The major ellagitannins of pomegranate by-products, as well as pomegranate products (fruit and juice), are punicalagins (Gil et al., 2000; Fischer et al., 2011; Qu et al., 2012).
Pomegranate extract contains high percentages of phenolic compounds and showed antioxidant activities in a concentration-dependent manner as shown for both the DPPH and superoxide anion scavenging assay.
It has been reported that dietary plant polyphenols are able to selectively modulate the growth of susceptible microorganisms (Tabasco et al., 2011). Plant extracts commonly inhibit bacterial growth, but the magnitude of the effect depends on the composition of the extract and the type of bacterial strain.
Results obtained in our experimental conditions demonstrated that high concentrations of pomegranate polyphenols exert antimicrobial activity on some pathogen strains such as L. innocua and S. aureus. These results are in agreement with studies of Panichayupakaranant et al. (2010), Fawole et al. (2012), and Su et al. (2012).
However, at concentrations of PE lower to 0.34 mg/ml, although none inhibitory activity concentrations was detected against the probiotic strains, only a slight increase in growth of LGG was evaluated. These results are not in agreement with studies of Li et al. (2015) and of Neyrinck et al. (2013) that demonstrated that pomegranate polyphenols may potentially work as prebiotics.
Obesity is a condition in which the lipids have accumulated leading to expansion of the adipose tissue that acts as a metabolic and endocrine organ. The molecular mechanisms that modulate pre-adipocytes growth, differentiation, and lipogenesis of fat cells have been subjected to extensive studies (Vanella et al., 2012; Stechschulte et al., 2014; Moseti et al., 2016; Palmeri et al., 2016; Waldman et al., 2016; Carpene et al., 2018).
During adipocyte differentiation, preadipocytes differentiate into mature adipocytes (Lefterova and Lazar, 2009). Increased fat accumulation is strongly correlated with cell number and/or size of adipocytes (Jiang et al., 2008).
It has been reported that the degree of obesity is related to the differentiation of preadipocytes in adipocytes and with enlarged adipocytes in adipose tissues (Wang and Jones, 2004).
Other authors reported that PEs were able to suppress preadipocyte differentiation and adipogenesis and to ameliorate fatty liver in the rats with obesity and type 2 diabetes (Xu et al., 2009).
In agreement with data of Moon et al. (2012) and Park et al. (2014) in our experimental conditions PE, LGG-T0, and LGG-T1 resulted in a significant reduction in lipid accumulation in 3T3-L1 cells during differentiation into adipocytes suggesting that PE, LGG-T0, and LGG-T1 are able to suppress adipocyte differentiation. However, the treatment with LGG-filtered SB derived from cells incubated with PE (LGG-T1) or without (LGG-T1) was similar. In our experimental conditions, in fact, it was not observed the prebiotic effect demonstrated by other authors. Moreover, the combination treatment of PE and LGG-T1 was the most effective in reducing intracellular lipid accumulation. These data demonstrate that, even if in our experimental conditions it was not observed a prebiotic effect, filtered SB obtained from LGG incubated with PE (LGG-T1), might contain, besides the beneficial bacterial secreted bioactive compounds, also small amounts of PE-derived bioactive compounds. The latter, present in small amounts in LGG-T1, would not be able to exert higher beneficial effects than LGG-T0, but in combination with PE could have potential synergistic health benefits.
Adipocyte-specific peroxisome proliferator-activated receptor-γ (PPARγ) is involved in the early stage of adipocyte differentiation (Rosen et al., 2000) regulating the expression of adipogenic genes such as fatty acid synthase (FAS) and sterol regulatory element-binding proteins (SREBP) and then triggering the accumulation of fat in the cells (Kawada et al., 2001; Berger and Moller, 2002).
Adipose tissue is not only a primary fat reservoir, but it is also an endocrine organ which controls lipid homeostasis. Altered levels of adipose tissue-derived adipokines can contribute in developing of inflammation, resulting in impaired lipid metabolism (Armani et al., 2010). In chronic inflammation, proinflammatory cytokines such as IL-6 are upregulated while antiflammatory cytokines such as IL-10 are downregulated (Kershaw and Flier, 2004; Bradley et al., 2008; Lira et al., 2012; Liu et al., 2018).
Our results demonstrate that the combination treatment with PE+LGG-T1 significantly downregulated the mRNA levels of adiponectin, FAS, and IL-6 and upregulated IL-10.
We can conclude that the combination treatment with PE+LGG-T1 possesses anti-inflammatory properties and it is able to inhibit the adipocyte differentiation by modulating the expression levels of key adipogenic transcription factors involved in adipogenesis.
Conclusion
Pomegranate extract- and LGG-filtered SB significantly decreased intracellular lipid accumulation. A synergistic effect of probiotics and polyphenols contained in PE was observed. Moreover, our results evidenced that combination treatment of PE+LGG T1 was the most effective in reducing mRNA expression levels of Adiponectin, IL-6, FAS, and in upregulating IL-10.
These results evidenced that probiotics and polyphenols contained in PE may affect adipogenesis in vitro. Moreover, our results demonstrate that the synergistic properties of combining foods such as pomegranate and probiotics may exert combined health benefits.
Then pomegranate and probiotics such as LGG strain may contribute in development of new nutraceutical/probiotic-based remedies to prevent and to treat obesity.
Author Contributions
VS, LV, CR, CC, FR, and GB collected research articles, conceived the experiments, analyzed the results, and wrote the manuscript. CR, MR, SF, and NT conducted the experiments.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
Al-Zoreky, N. S. (2009). Antimicrobial activity of pomegranate (Punica granatum L.) fruit peels. Int. J. Food Microbiol. 134, 244–248. doi: 10.1016/j.ijfoodmicro.2009.07.002
Armani, A., Mammi, C., Marzolla, V., Calanchini, M., Antelmi, A., Rosano, G. M., et al. (2010). Cellular models for understanding adipogenesis, adipose dysfunction, and obesity. J. Cell Biochem. 110, 564–572. doi: 10.1002/jcb.22598
Barbagallo, I., Li Volti, G., Sorrenti, V., Di Giacomo, C., Acquaviva, R., Raffaele, M., et al. (2017). Caffeic acid phenethyl ester restores adipocyte gene profile expression following lipopolysaccharide treatment. Lett. Drug Des. Discov. 14, 481–487. doi: 10.2174/1570180813666160901124707
Bassiri-Jahromi, S. (2018). Punica granatum (Pomegranate) activity in health promotion and cancer prevention. Oncol. Rev. 12:345. doi: 10.4081/oncol.2018.345
Basu, A., and Penugonda, K. (2009). Pomegranate juice: a heart-healthy fruit juice. Nutr. Rev. 67, 49–56. doi: 10.1111/j.1753-4887.2008.00133.x
Berger, J., and Moller, D. E. (2002). The mechanisms of action of PPARs. Annu. Rev. Med. 53, 409–435. doi: 10.1146/annurev.med.53.082901.104018
Bialonska, D., Kasimsetty, S. G., Schrader, K. K., and Ferreira, D. (2009). The effect of pomegranate (Punica granatum L.) byproducts and ellagitannins on the growth of human gut bacteria. J. Agric. Food Chem. 57, 8344–8349. doi: 10.1021/jf901931b
Bialonska, D., Ramnani, P., Kasimsetty, S. G., Muntha, K. R., Gibson, G. R., and Ferreira, D. (2010). The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota. Int. J. Food Microbiol. 140, 175–182. doi: 10.1016/j.ijfoodmicro.2010.03.038
Bradley, R. L., Fisher, F. F., and Maratos-Flier, E. (2008). Dietary fatty acids differentially regulate production of TNF-alpha and IL-10 by murine 3T3-L1 adipocytes. Obesity 16, 938–944. doi: 10.1038/oby.2008.39
Carpene, C., Pejenaute, H., Del Moral, R., Boulet, N., Hijona, E., Andrade, F., et al. (2018). The dietary antioxidant piceatannol inhibits adipogenesis of human adipose mesenchymal stem cells and limits glucose transport and lipogenic activities in adipocytes. Int. J. Mol. Sci. 19:E2081. doi: 10.3390/ijms19072081
Dhumal, S. S., Karale, A. R., Jadhav, S. B., and Kad, V. P. (2014). Recent advances and the developments in the pomegranate processing and utilization: a review. J. Agric. Crop Sci. 1, 1–17.
Di Giacomo, C., Vanella, L., Sorrenti, V., Santangelo, R., Barbagallo, I., Calabrese, G., et al. (2015). Effects of tithonia diversifolia (Hemsl.) A. Gray extract on adipocyte differentiation of human mesenchymal stem cells. PLoS One 10:e0122320. doi: 10.1371/journal.pone.0122320
Fawole, O. A., Makunga, N. P., and Opara, U. L. (2012). Antibacterial, antioxidant and tyrosinase-inhibition activities of pomegranate fruit peel methanolic extract. BMC Complement. Altern. Med. 12:200. doi: 10.1186/1472-6882-12-200
Fischer, U. A., Carle, R., and Kammerer, D. R. (2011). Identification and quantification of phenolic compounds from pomegranate (Punica granatum L.) peel, mesocarp, aril and differently produced juices by HPLC-DAD-ESI/MS(n). Food Chem. 127, 807–821. doi: 10.1016/j.foodchem.2010.12.156
Gil, M. I., Tomas-Barberan, F. A., Hess-Pierce, B., Holcroft, D. M., and Kader, A. A. (2000). Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J. Agric. Food Chem. 48, 4581–4589.
Hossin, F. L. A. (2009). Effect of pomegranate (Punica granatum) peels and it’s extract on obese hypercholesterolemic rats. Pak. J. Nutr. 8, 1251–1257. doi: 10.3923/pjn.2009.1251.1257
Jiang, L., Zhang, N. X., Mo, W., Wan, R., Ma, C. G., Li, X., et al. (2008). Rehmannia inhibits adipocyte differentiation and adipogenesis. Biochem. Biophys. Res. Commun. 371, 185–190. doi: 10.1016/j.bbrc.2008.03.129
Kawada, T., Takahashi, N., and Fushiki, T. (2001). Biochemical and physiological characteristics of fat cell. J. Nutr. Sci. Vitaminol. 47, 1–12.
Kershaw, E. E., and Flier, J. S. (2004). Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89, 2548–2556. doi: 10.1210/jc.2004-0395
Kim, S. H., and Plutzky, J. (2016). Brown fat and browning for the treatment of obesity and related metabolic disorders. Diabetes Metab. J. 40, 12–21. doi: 10.4093/dmj.2016.40.1.12
Lai, C. S., Tsai, M. L., Badmaev, V., Jimenez, M., Ho, C. T., and Pan, M. H. (2012). Xanthigen suppresses preadipocyte differentiation and adipogenesis through down-regulation of PPARgamma and C/EBPs and modulation of SIRT-1, AMPK, and FoxO pathways. J. Agric. Food Chem. 60, 1094–1101. doi: 10.1021/jf204862d
Lee, C. J., Chen, L. G., Liang, W. L., and Wang, C. C. (2010). Anti-inflammatory effects of punica granatum Linne in vitro and in vivo. Food Chem. 118, 315–322.
Lefterova, M. I., and Lazar, M. A. (2009). New developments in adipogenesis. Trends Endocrinol. Metab. 20, 107–114. doi: 10.1016/j.tem.2008.11.005
Les, F., Arbones-Mainar, J. M., Valero, M. S., and Lopez, V. (2018). Pomegranate polyphenols and urolithin A inhibit alpha-glucosidase, dipeptidyl peptidase-4, lipase, triglyceride accumulation and adipogenesis related genes in 3T3-L1 adipocyte-like cells. J. Ethnopharmacol. 220, 67–74. doi: 10.1016/j.jep.2018.03.029
Li, Y. F., Guo, C. J., Yang, J. J., Wei, J. Y., Xu, J., and Cheng, S. (2006). Evaluation of antioxidant properties of pomegranate peel extract in comparison with pomegranate pulp extract. Food Chem. 96, 254–260.
Li, Z., Summanen, P. H., Komoriya, T., Henning, S. M., Lee, R. P., Carlson, E., et al. (2015). Pomegranate ellagitannins stimulate growth of gut bacteria in vitro: implications for prebiotic and metabolic effects. Anaerobe 34, 164–168. doi: 10.1016/j.anaerobe.2015.05.012
Lin, L. T., Chen, T. Y., Lin, S. C., Chung, C. Y., Lin, T. C., Wang, G. H., et al. (2013). Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry. BMC Microbiol. 13:187. doi: 10.1186/1471-2180-13-187
Lira, F. S., Rosa, J. C., Pimentel, G. D., Seelaender, M., Damaso, A. R., Oyama, L. M., et al. (2012). Both adiponectin and interleukin-10 inhibit LPS-induced activation of the NF-kappaB pathway in 3T3-L1 adipocytes. Cytokine 57, 98–106. doi: 10.1016/j.cyto.2011.10.001
Liu, Y., Xu, D., Yin, C., Wang, S., Wang, M., and Xiao, Y. (2018). IL-10/STAT3 is reduced in childhood obesity with hypertriglyceridemia and is related to triglyceride level in diet-induced obese rats. BMC Endocr. Disord. 18:39. doi: 10.1186/s12902-018-0265-z
Moon, Y. J., Soh, J. R., Yu, J. J., Sohn, H. S., Cha, Y. S., and Oh, S. H. (2012). Intracellular lipid accumulation inhibitory effect of Weissella koreensis OK1-6 isolated from Kimchi on differentiating adipocyte. J. Appl. Microbiol. 113, 652–658. doi: 10.1111/j.1365-2672.2012.05348.x
Moseti, D., Regassa, A., and Kim, W. K. (2016). Molecular regulation of adipogenesis and potential anti-adipogenic bioactive molecules. Int. J. Mol. Sci. 17:E124. doi: 10.3390/ijms17010124
Neyrinck, A. M., Van Hee, V. F., Bindels, L. B., De Backer, F., Cani, P. D., and Delzenne, N. M. (2013). Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: potential implication of the gut microbiota. Br. J. Nutr. 109, 802–809. doi: 10.1017/S0007114512002206
Palmeri, R., Monteleone, J. I., Spagna, G., Restuccia, C., Raffaele, M., Vanella, L., et al. (2016). Olive leaf extract from sicilian cultivar reduced lipid accumulation by inducing thermogenic pathway during adipogenesis. Front. Pharmacol. 7:143. doi: 10.3389/fphar.2016.00143
Panichayupakaranant, P., Tewtrakul, S., and Yuenyongsawad, S. (2010). Antibacterial, anti-inflammatory and anti-allergic activities of standardised pomegranate rind extract. Food Chem. 123, 400–403. doi: 10.1055/s-0030-1264706
Park, J. E., Oh, S. H., and Cha, Y. S. (2014). Lactobacillus brevis OPK-3 isolated from kimchi inhibits adipogenesis and exerts anti-inflammation in 3T3-L1 adipocyte. J. Sci. Food Agric. 94, 2514–2520. doi: 10.1002/jsfa.6588
Qu, W., Breksa Iii, A. P., Pan, Z., and Ma, H. (2012). Quantitative determination of major polyphenol constituents in pomegranate products. Food Chem. 132, 1585–1591. doi: 10.1016/j.foodchem.2011.11.106
Raffaele, M., Barbagallo, I., Licari, M., Carota, G., Sferrazzo, G., Spampinato, M., et al. (2018). N-Acetylcysteine (NAC) ameliorates lipid-related metabolic dysfunction in bone marrow stromal cells-derived adipocytes. Evid. Based Complement. Altern. Med. 2018:9. doi: 10.1155/2018/5310961
Reddy, M. K., Gupta, S. K., Jacob, M. R., Khan, S. I., and Ferreira, D. (2007). Antioxidant, antimalarial and antimicrobial activities of tannin-rich fractions, ellagitannins and phenolic acids from Punica granatum L. Planta Med. 73, 461–467. doi: 10.1055/s-2007-967167
Romeo, F. V., Ballistreri, G., Fabroni, S., Pangallo, S., Nicosia, M. G., Schena, L., et al. (2015). Chemical characterization of different sumac and pomegranate extracts effective against botrytis cinerea rots. Molecules 20, 11941–11958. doi: 10.3390/molecules200711941
Rosen, E. D., Walkey, C. J., Puigserver, P., and Spiegelman, B. M. (2000). Transcriptional regulation of adipogenesis. Genes Dev. 14, 1293–1307.
Salerno, L., Modica, M. N., Romeo, G., Pittala, V., Siracusa, M. A., Amato, M. E., et al. (2012). Novel inhibitors of nitric oxide synthase with antioxidant properties. Eur. J. Med. Chem. 49, 118–126. doi: 10.1016/j.ejmech.2012.01.002
Singleton, V. L., Orthofer, R., and Lamuela-Raventos, R. M. (1999). Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin–Ciocalteau reagent. Methods Enzymol. 299, 152–178. doi: 10.1016/S0076-6879(99)99017-1
Smith, K. B., and Smith, M. S. (2016). Obesity Statistics. Prim Care 43, 121–135. doi: 10.1016/j.pop.2015.10.001
Stechschulte, L. A., Hinds, TD Jr, Khuder, S. S., Shou, W., Najjar, S. M., and Sanchez, E. R. (2014). FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRalpha and PPARgamma. Mol. Endocrinol. 28, 1265–1275. doi: 10.1210/me.2014-1022
Su, X., Howell, A. B., and D’Souza, D. H. (2012). Antibacterial effects of plant-derived extracts on methicillin-resistant Staphylococcus aureus. Foodborne Pathog. Dis. 9, 573–578. doi: 10.1089/fpd.2011.1046
Tabasco, R., Sanchez-Patan, F., Monagas, M., Bartolome, B., Victoria Moreno-Arribas, M., Pelaez, C., et al. (2011). Effect of grape polyphenols on lactic acid bacteria and bifidobacteria growth: resistance and metabolism. Food Microbiol. 28, 1345–1352. doi: 10.1016/j.fm.2011.06.005
Tehranifar, A., Selahvarzi, Y., Kharrazi, M., and Bakhsh, V. J. (2011). High potential of agro-industrial by-products of pomegranate (Punica granatum L.) as the powerful antifungal and antioxidant substances. Ind. Crops Product 34, 1523–1527. doi: 10.1016/j.indcrop.2011.05.007
Vanella, L., Barbagallo, I., Acquaviva, R., Di Giacomo, C., Cardile, V., Abraham, N. G., et al. (2013a). Ellagic acid: cytodifferentiating and antiproliferative effects in human prostatic cancer cell lines. Curr. Pharm. Des. 19, 2728–2736.
Vanella, L., Di Giacomo, C., Acquaviva, R., Barbagallo, I., Cardile, V., Kim, D. H., et al. (2013b). Apoptotic markers in a prostate cancer cell line: effect of ellagic acid. Oncol. Rep. 30, 2804–2810. doi: 10.3892/or.2013.2757
Vanella, L., Di Giacomo, C., Acquaviva, R., Barbagallo, I., Li Volti, G., Cardile, V., et al. (2013c). Effects of ellagic acid on angiogenic factors in prostate cancer cells. Cancers 5, 726–738. doi: 10.3390/cancers5020726
Vanella, L., Sanford, C. Jr., Kim, D. H., Abraham, N. G., and Ebraheim, N. (2012). Oxidative stress and heme oxygenase-1 regulated human mesenchymal stem cells differentiation. Int. J. Hypertens. 2012:890671. doi: 10.1155/2012/890671
Waldman, M., Bellner, L., Vanella, L., Schragenheim, J., Sodhi, K., Singh, S. P., et al. (2016). Epoxyeicosatrienoic Acids Regulate Adipocyte Differentiation of Mouse 3T3 Cells, Via PGC-1alpha Activation, Which Is Required for HO-1 Expression and Increased Mitochondrial Function. Stem Cells Dev. 25, 1084–1094. doi: 10.1089/scd.2016.0072
Wang, Y. W., and Jones, P. J. (2004). Conjugated linoleic acid and obesity control: efficacy and mechanisms. Int. J. Obes. Relat. Metab. Disord. 28, 941–955. doi: 10.1038/sj.ijo.0802641
Keywords: lactobacilli, antimicrobial activity, pomegranate extract, adipocyte differentiation, combining foods
Citation: Sorrenti V, Randazzo CL, Caggia C, Ballistreri G, Romeo FV, Fabroni S, Timpanaro N, Raffaele M and Vanella L (2019) Beneficial Effects of Pomegranate Peel Extract and Probiotics on Pre-adipocyte Differentiation. Front. Microbiol. 10:660. doi: 10.3389/fmicb.2019.00660
Received: 22 October 2018; Accepted: 15 March 2019;
Published: 03 April 2019.
Edited by:
Rosalba Lanciotti, University of Bologna, ItalyReviewed by:
Anna Reale, Istituto di Scienza dell’Alimentazione (ISA), ItalyKoshy Philip, University of Malaya, Malaysia
Copyright © 2019 Sorrenti, Randazzo, Caggia, Ballistreri, Romeo, Fabroni, Timpanaro, Raffaele and Vanella. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Valeria Sorrenti, sorrenti@unict.it